Filtered By:
Countries: Germany Health
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 445 results found since Jan 2013.
Hypereosinophilic syndrome in Europe: retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization
CONCLUSION: Patients with HES across five European countries had a substantial disease burden despite extensive OCS treatment, highlighting the need for additional targeted therapies.PMID:36863663 | DOI:10.1016/j.anai.2023.02.022
Source: Annals of Allergy, Asthma and Immunology - March 2, 2023 Category: Allergy & Immunology Authors: Jeremiah Hwee Lynn Huynh Shawn Du Namhee Kwon Rupert W Jakes Rafael Alfonso-Cristancho Lee Baylis Gema Requena Anamika Khanal Marc E Rothenberg Mei Sheng Duh Source Type: research
Sheep cheese allergy in Alpha-gal Syndrome
J Investig Allergol Clin Immunol. 2023 Feb 21:0. doi: 10.18176/jiaci.0897. Online ahead of print.NO ABSTRACTPMID:36811837 | DOI:10.18176/jiaci.0897
Source: Journal of Investigational Allergology and Clinical Immunology - February 22, 2023 Category: Allergy & Immunology Authors: A German-Sanchez A Alonso-Llamazares M D Latorre-Iba ñez B Bartolome-Zavala I Antepara-Ercoreca Source Type: research
Case studies expose deadly risk of mpox to people with untreated HIV
In June 2022, a young man in his 30s severely sick with mpox, the viral disease formerly known as monkeypox, was admitted to the Salvador Zubirán National Institute of Health Sciences and Nutrition hospital in Mexico City. Tests showed the patient was also HIV-positive, which he had not known, and that his blood had few CD4 cells, critical immune cells that HIV attacks. The man’s immune system was so weak it could not keep mpox in check and painful lesions kept spreading across his body, eating away at, or necrotizing, the flesh, according to HIV researcher Brenda Crabtree Ramirez, who was on his care team. Then the vir...
Source: Science of Aging Knowledge Environment - February 21, 2023 Category: Geriatrics Source Type: research
Case studies expose deadly risk of mpox in people with untreated HIV
In June 2022, a young man in his 30s severely sick with mpox, the viral disease formerly known as monkeypox, was admitted to the Salvador Zubirán National Institute of Health Sciences and Nutrition hospital in Mexico City. Tests showed the patient was also HIV-positive, which he had not known, and that his blood had few CD4 cells, critical immune cells that HIV attacks. The man’s immune system was so weak it could not keep mpox in check and painful lesions kept spreading across his body, eating away at, or necrotizing, the flesh, according to HIV researcher Brenda Crabtree Ramirez, who was on his care team. Then the vir...
Source: ScienceNOW - February 21, 2023 Category: Science Source Type: news
Down-Modulation of Cockroach (CR) Allergen-specific Th2 Cell Responses Following Subcutaneous German Cockroach Allergen Immunotherapy (SCIT)
The responses of T cells to subcutaneous allergen immunotherapy (SCIT) are not fully elucidated. We conducted a functional immunological evaluation of cockroach (CR) allergen-specific CD4+ T cell reactivity in the double-blinded, placebo-controlled, multi-center CRITICAL study.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Ricardo Da Silva Antunes, April Frazier, Anna Pom és, Augustin Calatroni, Robert Wood, George O'Connor, Jacqueline Pongracic, Gurjit Khurana Hershey, Carolyn Kercsmar, Michelle Gill, Andrew Liu, Edward Zoratti, Meyer Kattan, Paula Busse, Leonard Bacharie Source Type: research
The Effect of Subcutaneous German Cockroach Immunotherapy (SCIT) on Nasal Allergen Challenge (NAC) and Cockroach-specific Antibody Responses Among Urban Children and Adolescents
Cockroach allergy contributes to asthma and rhinitis morbidity among many urban children. Treatment with cockroach SCIT could be beneficial.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Edward Zoratti, Robert Wood, George O, Jacqueline Pongracic, Melanie Makhija, Gurjit Khurana Hershey, Michael Sherenian, Michelle Gill, Rebecca Gruchalla, Jeffrey Chambliss, Andrew Liu, Meyer Kattan, Paula Busse, Leonard Bacharier, Katherine Rivera-Spolja Source Type: research
Affinity-purified Vitellogenin/vitellin is a Major Component of Total Allergen Recognized by German Cockroach-specific IgE
We report here an affinity purification of Vg/Vn from whole body defatted powder from adult GCr.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Jay Slater, Alex Blank, Michael Strader, Kavita Sharma, Robert Hamilton, Coby Schal, Charles Bronzert Source Type: research
Knowledge mapping of immunotherapy for allergic rhinoconjunctivitis: a bibliometric study (2002-2021)
CONCLUSION: Over the past 20 years, the overall quality of research on immunotherapy for ARC has gradually improved, allowing the introduction of specific and targeted treatment. Currently, the main focus of ARC research is the novel routes of drug delivery and combined treatment with biological agents.PMID:36617823 | DOI:10.15586/aei.v51i1.714
Source: Allergologia et Immunopathologia - January 9, 2023 Category: Allergy & Immunology Authors: Na Chen Kun Zhang Youwei Li Ying Liu Source Type: research
